Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Donnelly, J. P.
Right arrow Articles by Verhagen, C. A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donnelly, J. P.
Right arrow Articles by Verhagen, C. A. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:505-507, 2003
© 2003 European Society for Medical Oncology

Editorial

Can anything be done about oral mucositis?

J. P. Donnelly, N. M. A. Blijlevens and C. A. H. Verhagen

The first 10% of the full text of this article appears below.

Oral mucositis continues to afflict most patients who are given chemotherapy with or without total body irradiation to prepare them for a haematopoietic stem cell transplant from peripheral blood or bone marrow. Besides the discomfort and pain caused, the intake of food and fluids can be severely curtailed, leading to dehydration and malnutrition, the risk of infection is increased, and there may even be a risk of other more serious complications such as hepatic veno-occlusion [1]. Throughout the last two decades there have been many attempts to identify remedies to prevent or at least ameliorate oral mucositis [2], but with mixed results. Moreover, the targets for these interventions have varied from bland rinses to growth . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
S. B. Vuyyuri, D. A. Hamstra, D. Khanna, C. A. Hamilton, S. M. Markwart, K. C.M. Campbell, P. Sunkara, B. D. Ross, and A. Rehemtulla
Evaluation of D-Methionine as a Novel Oral Radiation Protector for Prevention of Mucositis
Clin. Cancer Res., April 1, 2008; 14(7): 2161 - 2170.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. J. Stiff, C. Emmanouilides, W. I. Bensinger, T. Gentile, B. Blazar, T. C. Shea, J. Lu, J. Isitt, A. Cesano, and R. Spielberger
Palifermin Reduces Patient-Reported Mouth and Throat Soreness and Improves Patient Functioning in the Hematopoietic Stem-Cell Transplantation Setting
J. Clin. Oncol., November 20, 2006; 24(33): 5186 - 5193.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. S. Rosen, E. Abdi, I. D. Davis, J. Gutheil, F. M. Schnell, J. Zalcberg, A. Cesano, U. Gayko, M.-G. Chen, and S. Clarke
Palifermin Reduces the Incidence of Oral Mucositis in Patients With Metastatic Colorectal Cancer Treated With Fluorouracil-Based Chemotherapy
J. Clin. Oncol., November 20, 2006; 24(33): 5194 - 5200.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. Spielberger, P. Stiff, W. Bensinger, T. Gentile, D. Weisdorf, T. Kewalramani, T. Shea, S. Yanovich, K. Hansen, S. Noga, et al.
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
N. Engl. J. Med., December 16, 2004; 351(25): 2590 - 2598.
[Abstract] [Full Text] [PDF]